A comparative study of the clinical use of four placental proteins in the third trimester.
D006063:Chorionic Gonadotropin / Q000097:blood; D005260:Female; D005328:Fetal Viability; D006023:Glycoproteins; D006801:Humans; D010928:Placental Lactogen / Q000097:blood; D011247:Pregnancy; D011257:Pregnancy Proteins / Q000097:blood*; D011263:Pregnancy Trimester, Third; D011268:Pregnancy-Specific beta 1-Glycoproteins / Q000097:blood
D006063:Chorionic Gonadotropin; D006023:Glycoproteins; D011257:Pregnancy Proteins; D011268:Pregnancy-Specific beta 1-Glycoproteins; C021240:tissue-factor-pathway inhibitor 2; D010928:Placental Lactogen